register

ESG

Boehringer Ingelheim sets sustainability benchmark in NZ

Health Industry Hub | January 16, 2025 |

Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the New Zealand Green Building Council (NZGBC).

This achievement is particularly noteworthy as Boehringer Ingelheim becomes the first pharmaceutical company in the country to receive this recognition. Globally, the Auckland office now joins an elite group of spaces awarded the distinguished 6 Star Green Star rating, showcasing the company’s dedication to sustainable excellence.

Xiomara Sandoval, Chief Financial Officer for Australia and New Zealand at Boehringer Ingelheim, reflected on the significance of this accomplishment, saying “This certification shows we’re leading the way in sustainable office design and creating a space that’s not only welcoming but also inspiring for all our wonderful colleagues in New Zealand.

“Achieving this certification showcases our global leadership in office design, providing a space that’s inspiring and welcoming for all our New Zealand colleagues. Thank you to the team for their hard work and dedication in gaining this certification.”

Andrew Eagles, Chief Executive of NZGBC, applauded the achievement, saying “We love to see businesses taking up a sustainable, healthy approach to their office fitouts, and it’s exceptional to see the efforts Boehringer Ingelheim have made towards achieving the highest Green Star rating possible.

He further added, “Fewer than 10 New Zealand offices have achieved a 6 Star Green Star rating for their fitout, and this is the country’s first under the most recent version of the Green Star Interiors certification. A huge congratulations to all involved in creating a more efficient, sustainable space for staff to excel in.”

Boehringer’s 6 Star Green Star certification celebrates several standout features, including ergonomic, fully adjustable workstation furniture, layouts promoting health and environmental consciousness, and superior indoor air quality delivering twice the fresh air required by building codes. Advanced lighting systems with natural daylight sensors further enhance energy efficiency, while low-pollutant materials emphasise sustainability throughout the office design.

The Green Star system evaluates projects across 30 sustainability categories, providing an independent assessment of how buildings meet benchmark standards for low-carbon, sustainable design and construction.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Philips remote monitoring cuts hospital costs and ICU time by 69%

Philips remote monitoring cuts hospital costs and ICU time by 69%

Health Industry Hub | August 1, 2025 |

An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]

More


News - MedTech & Diagnostics

VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business

VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business

Health Industry Hub | August 1, 2025 |

VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]

More


News - Pharmaceuticals

New therapy PBS listed in advanced Parkinson’s disease - AbbVie Vyalev

New therapy PBS listed in advanced Parkinson’s disease

Health Industry Hub | August 1, 2025 |

A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]

More


News - Pharmaceuticals

PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions

PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions

Health Industry Hub | August 1, 2025 |

From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]

More


This content is copyright protected. Please subscribe to gain access.